A study to assess the mass balance of a novel antibiotic

• Research type

  Research Study

• Full title

  An Open-Label, Single Dose Study Designed to Assess the Mass Balance Recovery, Metabolite Profile and Identification of Metabolite Structure for [14C]-Eravacycline in Healthy Male Subjects after Oral and Intravenous Dosing

• IRAS ID

  151575

• Contact name

  Stuart Mair

• Contact email

  stuart.mair@quotientclinical.com

• Sponsor organisation

  Tetraphase Pharmaceuticals Inc.

• Eudract number

  2014-000538-52

• ISRCTN Number

  To be registered

• REC name

  Wales REC 1

• REC reference

  14/WA/0096

• Date of REC Opinion

  11 Apr 2014

• REC opinion

  Favourable Opinion